Trials / Recruiting
RecruitingNCT06500234
Nutrition Impact on Immunotherapy of Cancer
Phase III Study on the Relation of Nutrition and Immunotherapy of Cancer Patients
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Qingdao Central Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates nutritional status and outcomes of immuntherapy in cancer patients.
Detailed description
Studies have shown that more than half of the patients with cancer are also malnourished at diagnosis. This increases patients' risk of complications associated with the treatment as well as the abandonment of care, as well as decrease the level of survival rates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Megestrol Acetate and olanzapine | megestrol acetate, 160 mg, oral everyday; olanzapine 2.5 mg, oral everyday |
| DRUG | Starch powder 50 mg | Starch powder 50 mg, oral, everyday |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-05-31
- Completion
- 2027-05-31
- First posted
- 2024-07-15
- Last updated
- 2024-07-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06500234. Inclusion in this directory is not an endorsement.